文献速递白血病MDS 与骨髓增殖性肿瘤造血干细胞移植与细胞治疗

MYB不足破坏造血干细胞蛋白稳态,导致年龄相关肿瘤

MYB insufficiency disrupts proteostasis in hematopoietic stem cells, leading to age-related neoplasia.
PubMed 文献 · Blood · 2023-01-01

研究在小鼠中建立Myb不足模型,观察到其晚年发生骨髓增殖性肿瘤、骨髓增生异常和白血病,与人类等效疾病的年龄特征一致。年龄依赖性源于造血干细胞内在缺陷:多基因表达微小改变导致的初始细胞状态缺陷,以及渐进积累的细微变化。年轻Myb不足小鼠出现蛋白酶体活性改变、增殖指标升高及后续核糖体活性升高,作者提出这些改变共同导致蛋白稳态失衡,可能创造利于疾病起始的细胞环境。

要点

  • Myb不足小鼠晚年发生骨髓增殖性肿瘤、骨髓增生异常和白血病,模拟人类疾病年龄特征。
  • 年龄依赖性源于造血干细胞内在缺陷,涉及初始细胞状态缺陷和渐进积累的细微变化。
  • 年轻Myb不足小鼠显示蛋白酶体活性改变、增殖指标升高及后续核糖体活性升高。

核心结论

  • Myb不足通过破坏造血干细胞蛋白稳态,导致年龄相关肿瘤发生。

研究设计与样本

  • 小鼠Myb不足模型研究。

主要发现

  • Myb不足小鼠晚年发生骨髓增殖性肿瘤、骨髓增生异常和白血病,与人类等效疾病年龄特征一致。
  • 年龄依赖性源于造血干细胞内在缺陷,涉及多基因表达微小改变导致的初始细胞状态缺陷和渐进积累的细微变化。
  • 年轻Myb不足小鼠出现蛋白酶体活性改变、增殖指标升高,随后核糖体活性升高。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

MYB plays a key role in gene regulation throughout the hematopoietic hierarchy and is critical for the maintenance of normal hematopoietic stem cells (HSC). Acquired genetic dysregulation of MYB is involved in the etiology of a number of leukemias, although inherited noncoding variants of the MYB gene are a susceptibility factor for many hematological conditions, including myeloproliferative neoplasms (MPN). The mechanisms that connect variations in MYB levels to disease predisposition, especially concerning age dependency in disease initiation, are completely unknown. Here, we describe a model of Myb insufficiency in mice that leads to MPN, myelodysplasia, and leukemia in later life, mirroring the age profile of equivalent human diseases. We show that this age dependency is intrinsic to HSC, involving a combination of an initial defective cellular state resulting from small effects on the expression of multiple genes and a progressive accumulation of further subtle changes. Similar to previous studies showing the importance of proteostasis in HSC maintenance, we observed altered proteasomal activity and elevated proliferation indicators, followed by elevated ribosome activity in young Myb-insufficient mice. We propose that these alterations combine to cause an imbalance in proteostasis, potentially creating a cellular milieu favoring disease initiation.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Clarke ML, Lemma RB, Walton DS, et al. MYB insufficiency disrupts proteostasis in hematopoietic stem cells, leading to age-related neoplasia. Blood. 2023. PMID: 36603185. doi:10.1182/blood.2022019138

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。